Company intelligence / Profile preview
Acarpia Farmaceutici
Milan, Lombardy, Italyacarpia.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
Acarpia Farmaceutici develops and commercializes established, well-known small molecule drugs (e.g., colchicine, acetylsalicylic acid combinations, troxerutin/carbazochrome, alizapride hydrochloride) targeting cardiovascular, rheumatology, and other therapeutic areas, primarily through product repositioning and value enhancement. The company recently expanded access to its products in the Caribbean (CARICOM) and Mexico through a strategic partnership.
- Therapeutic areas
- ImmunologyRheumatologyInfectious DiseasesGastroenterologyHematologyCardiovascularOtherNeurologyWomen's Health
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
EarlyHealth Group
Beyond the preview
Go deeper on Acarpia Farmaceutici.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acarpia Farmaceutici.